news

Our latest
Press Releases & Updates

Latest press releases

RetinAI receives Innosuisse certificate

RetinAI Medical has received the prestigious Innosuisse Certificate of quality, which is awarded to Swiss startup companies ready for growth & scale-up.

RetinAI Announces Collaboration with Novartis to Provide Artificial Intelligence Solutions in Ophthalmology

RetinAI Medical AG announced a multi-year collaboration with Novartis Pharma AG under which RetinAI’s IT solutions and artificial intelligence tools shall be employed to support multiple projects in ophthalmology and digital health.

RetinAI receives ISO 13485:2016 certification

RetinAI has just received the ISO 13485:2016 certification, an important recognition awarded by regulatory bodies and necessary for companies willing to develop and commercialise Medical Devices.

btov Partners leads CHF 2.3M investment into RetinAI to bring Artificial Intelligence to Health Data

RetinAI, a Bern based company building software tools to aggregate, manage, and analyse health data, has closed a CHF 2.3M pre-Series A financing round. btov Partners' Industrial Technologies Fund has led the round with participation of Swiss-based investor network Investiere and a consortium of selected private investors...

Latest updates

Venture Kick Phase III [DECEMBER'17]

Early detection of eye diseases is key for effective treatment to reduce the onset of blindness. However, the patient’s journey to diagnosis is often long and involves many challenges. Venture Kick just awarded RetinAI with 130'000.- CHF to make eye care accessible and affordable to everyone via artificial intelligence.

Read more

5th Medtech & Digital Health Forum Basel [OCTOBER'17]

RetinAI participated in the latest edition of the 5th Medtech & Digital Health Forum in Basel. The team had the opportunity to present our current developments and efforts towards bringing Artificial Intelligence to Ophthalmology, specially in developing countries.

NVIDIA GTC Munich 2017 [OCTOBER'17]

RetinAI held a presentation during the last edition of the Nvidia GTC Europe in Munich, covering how ophthalmology is changing with Machine Learning. Stefanos Apostolopoulos (Technical Director) and Dr. Sandro De Zanet (Scientific Director) presented the efforts the company is doing to improve medical eye care around the world.

Euretina 2017 + MICCAI 2017 [AUGUST'17]

RetinAI is getting ready for a September full of conferences and events! September 7-10th we will be in the 17th EURETINA Congress in Barcelona, followed by 4 days in MICCAI'2017 in Quebec. In Canada we will present our work on automatic segmentation of pathological retinal layers and participate in this year's edition of the RETOUCH challenge.

Contact us for more informations! We are happy to hear from you!